These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 12798745)

  • 21. Comparison between one day and two days protocols for sentinel node mapping of breast cancer patients.
    Ali J; Alireza R; Mostafa M; Naser FM; Bahram M; Ramin S
    Hell J Nucl Med; 2011; 14(3):313-5. PubMed ID: 22087458
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sentinel lymph node biopsy without axillary lymphadenectomy after neoadjuvant chemotherapy is accurate and safe for selected patients: the GANEA 2 study.
    Classe JM; Loaec C; Gimbergues P; Alran S; de Lara CT; Dupre PF; Rouzier R; Faure C; Paillocher N; Chauvet MP; Houvenaeghel G; Gutowski M; De Blay P; Verhaeghe JL; Barranger E; Lefebvre C; Ngo C; Ferron G; Palpacuer C; Campion L
    Breast Cancer Res Treat; 2019 Jan; 173(2):343-352. PubMed ID: 30343457
    [TBL] [Abstract][Full Text] [Related]  

  • 23. FDG-PET for axillary lymph node staging in primary breast cancer.
    Crippa F; Gerali A; Alessi A; Agresti R; Bombardieri E
    Eur J Nucl Med Mol Imaging; 2004 Jun; 31 Suppl 1():S97-102. PubMed ID: 15133635
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Modifications of the learning curve guidelines for breast cancer sentinel node biopsy.
    Sanidas EE; Daskalakis M; Sbyrakis N; Tsiftsis DD
    Eur J Surg Oncol; 2005 May; 31(4):357-63. PubMed ID: 15837039
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical axillary recurrence in breast cancer patients after a negative sentinel node biopsy.
    Chung MA; Steinhoff MM; Cady B
    Am J Surg; 2002 Oct; 184(4):310-4. PubMed ID: 12383890
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Multicenter trial of sentinel node biopsy for breast cancer using both technetium sulfur colloid and isosulfan blue dye.
    Tafra L; Lannin DR; Swanson MS; Van Eyk JJ ; Verbanac KM; Chua AN; Ng PC; Edwards MS; Halliday BE; Henry CA; Sommers LM; Carman CM; Molin MR; Yurko JE; Perry RR; Williams R
    Ann Surg; 2001 Jan; 233(1):51-9. PubMed ID: 11141225
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Accuracy of axillary sentinel lymph node biopsy following neoadjuvant (induction) chemotherapy for carcinoma of the breast.
    Schwartz GF; Meltzer AJ
    Breast J; 2003; 9(5):374-9. PubMed ID: 12968956
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Optimization of sentinel lymph node biopsy in breast cancer by intraoperative axillary palpation].
    Serrano Vicente J; Infante de la Torre JR; Domínguez Grande ML; García Bernardo L; Durán Barquero C; Rayo Madrid JI; Sánchez Sánchez R; Correa Antúnez MI; Amaya Lozano JL; Conde Martín AF
    Rev Esp Med Nucl; 2010; 29(1):8-11. PubMed ID: 20015577
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sentinel lymph node biopsy alone without axillary lymph node dissection--follow up of sentinel lymph node negative breast cancer patients.
    Reitsamer R; Peintinger F; Prokop E; Menzel C; Cimpoca W; Rettenbacher L
    Eur J Surg Oncol; 2003 Apr; 29(3):221-3. PubMed ID: 12657230
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation of sentinel lymph node biopsy after previous breast surgery for breast cancer: GATA study.
    Renaudeau C; Lefebvre-Lacoeuille C; Campion L; Dravet F; Descamps P; Ferron G; Houvenaeghel G; Giard S; Tunon de Lara C; Dupré PF; Fritel X; Ngô C; Verhaeghe JL; Faure C; Mezzadri M; Damey C; Classe JM
    Breast; 2016 Aug; 28():54-9. PubMed ID: 27214241
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Use of axillary ultrasound, ultrasound-fine needle aspiration biopsy and magnetic resonance imaging in the preoperative triage of breast cancer patients considered for sentinel node biopsy.
    García Fernández A; Fraile M; Giménez N; Reñe A; Torras M; Canales L; Torres J; Barco I; González S; Veloso E; González C; Cirera L; Pessarrodona A
    Ultrasound Med Biol; 2011 Jan; 37(1):16-22. PubMed ID: 21144955
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effect of lymphatic tumor burden on sentinel lymph node biopsy results.
    Wong SL; Edwards MJ; Chao C; Simpson D; McMasters KM
    Breast J; 2002; 8(4):192-8. PubMed ID: 12100110
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Intraoperative palpation for clinically suspicious axillary sentinel lymph nodes reduces the false-negative rate of sentinel lymph node biopsy in breast cancer.
    Carmon M; Olsha O; Rivkin L; Spira RM; Golomb E
    Breast J; 2006; 12(3):199-201. PubMed ID: 16684315
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sentinel-lymph-node-based management or routine axillary clearance? One-year outcomes of sentinel node biopsy versus axillary clearance (SNAC): a randomized controlled surgical trial.
    Gill G;
    Ann Surg Oncol; 2009 Feb; 16(2):266-75. PubMed ID: 19050973
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Sentinel node biopsy in T2 breast cancers larger than 3 cm and clinically negative axilla compared with the T1-T2 <3 cm standard indication].
    Ruano R; Ramos M; García-Talavera JR; García Macías MC; Martín de Arriba A; González-Orús JM; Iglesias M; Serrano E
    Rev Esp Med Nucl; 2008; 27(3):176-82. PubMed ID: 18570859
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Sentinel node in breast cancer. Experience of the Salah-Azaïz Institute of Tunis].
    Ben Hassouna J; Bouzid T; Chkir A; Kadri N; Goucha A; Slim I; Boussen H; Gamoudi A; Hechiche M; Ben Dhiab T; Rahal K
    Bull Cancer; 2010 Apr; 97(4):453-60. PubMed ID: 20392687
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Blue dye versus combined blue dye-radioactive tracer technique in detection of sentinel lymph node in breast cancer.
    Radovanovic Z; Golubovic A; Plzak A; Stojiljkovic B; Radovanovic D
    Eur J Surg Oncol; 2004 Nov; 30(9):913-7. PubMed ID: 15498633
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Sentinel lymphatic node biopsy for breast cancer in practice].
    Strnad P; Rob L; Krízová H; Zuntová A; Chod J; Halaska M
    Ceska Gynekol; 2005 Jul; 70(4):291-5. PubMed ID: 16128130
    [TBL] [Abstract][Full Text] [Related]  

  • 39. FDG PET positive lymph nodes are highly predictive of metastasis in breast cancer.
    Kumar R; Zhuang H; Schnall M; Conant E; Damia S; Weinstein S; Chandra P; Czerniecki B; Alavi A
    Nucl Med Commun; 2006 Mar; 27(3):231-6. PubMed ID: 16479242
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Validation of lymphatic mapping and sentinel node biopsy in patients with symptomatic breast cancer.
    Cahill RA; Diamond L; Landers R; Walsh D; Watson RG
    Ir J Med Sci; 2006; 175(2):59-62. PubMed ID: 16872032
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.